2022年心胸外科团队围术期与重症监护年度综述
本文汇总了2022年与心脏手术围术期及重症监护管理相关的多个关键主题的专家意见,涵盖心脏手术患者血糖控制、白蛋白作为复苏液的目标导向液体治疗、术后谵妄的跨学科团队干预、静脉-静脉体外膜肺氧合治疗难治性低氧血症时的俯卧位通气,以及体外循环后难治性血管麻痹性休克的当代管理。
要点
- 约三分之一心脏手术患者合并糖尿病,综述了当代血糖管理以减少围术期并发症。
- 术后谵妄发生于20%至25%的心脏手术患者,讨论整合包括家属在内的跨学科团队干预方案。
- 综述了静脉-静脉体外膜肺氧合期间俯卧位通气支持数据及体外循环后血管麻痹性休克的管理证据。
核心结论
- 本文就心脏手术围术期和重症监护的多个关键主题提供专家意见,涉及血糖控制、液体治疗、谵妄管理、静脉-静脉体外膜肺氧合期间俯卧位通气及术后血管麻痹性休克。
研究设计与样本
- 专家意见综述,针对接受心脏手术及需要体外膜肺氧合患者的围术期与重症监护管理相关主题进行汇总。
主要发现
- 约三分之一接受心脏手术的患者合并糖尿病,综述了当代血糖控制管理以减少围术期并发症。
- 目标导向液体治疗仍存在兴趣与争议,综述了白蛋白作为复苏液的使用及近期临床试验数据。
- 谵妄被定义为急性意识混乱状态,发生于20%至25%的心脏手术后患者,讨论了整合包括家属在内的跨学科团队的谵妄团队方法方案。
- 静脉-静脉体外膜肺氧合治疗难治性低氧血症的最佳管理及俯卧位通气的作用仍是一个问题,综述了支持该技术在静脉-静脉体外膜肺氧合期间使用的数据。
- 提供了体外循环后难治性术后血管麻痹性休克的当代管理及支持证据。
局限性
- 原文未报告局限性
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
This year, we have again assembled an expert opinion on several key topics that pertain to the perioperative and critical care management of patients undergoing cardiac surgery and for patients requiring extracorporeal membrane oxygenation. Approximately 1 in 3 patients undergoing cardiac surgery have diabetes mellitus; contemporary glycemic control management of these patients to minimize perioperative complications are reviewed. Goal-directed fluid therapy remains an area on interest and controversy; the use of albumin as a resuscitation fluid and recent clinical trial data are reviewed. Delirium is characterized as an acute confusion state occurring in 20% to 25% of patients after cardiac surgery. Insights on integrating the whole interdisciplinary team, including the family, with the Delirium Team Approach program are discussed. Optimal management for refractory hypoxemia with venovenous extracorporeal membrane oxygenation and the role of prone positioning remain a question. Data supporting this technique during venovenous extracorporeal membrane oxygenation is reviewed-lastly, the contemporary management and supporting evidence for refractory postoperative vasoplegic shock after cardiopulmonary bypass is provided.
引用
- Arora RC, Chatterjee S, Milewski R, et al. 2022: Perioperative and critical care year in review for the cardiothoracic surgery team. J Thorac Cardiovasc Surg. 2024. PMID: 38795907. doi:10.1016/j.jtcvs.2024.05.011
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。